Eyad Almasri

Eyad Almasri, MD is a Clinical Professor at the University of California, San Francisco (UCSF) School of Medicine, specializing in Pulmonary Disease with board certifications in Internal Medicine, Pulmonary Medicine, Critical Care Medicine, and Sleep Medicine. He completed fellowships at the University of Pittsburgh and Western Pennsylvania Hospital. His clinical and research expertise spans pulmonary critical care, non-invasive prenatal testing using cell-free DNA (cfDNA), and genomic medicine. Dr. Almasri contributes to medical societies including the American College of Chest Physicians and Society of Critical Care Medicine.

Education & Training:

• B.Sc. in Science (Damascus University, 1992)
• MD in Medicine (Damascus Medical School, 1996)
• Internal Medicine Residencies at Damascus University Hospitals and University of Pittsburgh (1999-2003)
• Critical Care Medicine Fellowship (University of Pittsburgh, 2005)
• Pulmonary Disease Fellowship (Western Pennsylvania Hospital, 2008)
• Sleep Medicine Diplomate (2009)

Research Interests: Dr. Almasri’s work focuses on advancing cfDNA-based prenatal screening techniques for aneuploidies and copy number variants, particularly in multifetal gestations. He also investigates SARS-CoV-2 pathogenesis and extrapulmonary complications of COVID-19. His pulmonary research includes coccidioidomycosis management and stress cardiomyopathy associated with critical illness.

Publications & Trials: His recent studies address cfDNA applications in triplet pregnancies, efficacy of aviptadil/remdesivir for severe COVID-19, and genomic analysis in B-cell lymphomas. He contributed to major trials like TESICO and ACTT-4 evaluating antiviral therapies for hospitalized patients.

Professional Affiliations: Active member of ACCP, Society of Critical Care Medicine, and American Medical Association. Engages in academic senate committees and clinical trials coordination at UCSF.